NOROZARE Trademark

Trademark Overview


On Sunday, March 3, 2019, a trademark application was filed for NOROZARE with the United States Patent and Trademark Office. The USPTO has given the NOROZARE trademark a serial number of 88323511. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, October 15, 2019. This trademark is owned by Takeda Vaccines, Inc.. The NOROZARE trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
norozare

General Information


Serial Number88323511
Word MarkNOROZARE
Filing DateSunday, March 3, 2019
Status601 - ABANDONED - EXPRESS
Status DateTuesday, October 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesvaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTakeda Vaccines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events


Event DateEvent Description
Tuesday, October 15, 2019ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Tuesday, October 15, 2019ABANDONMENT - EXPRESS MAILED
Monday, October 14, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Monday, September 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, April 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION WRITTEN
Monday, April 22, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, March 6, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords


norozare human vaccines